Further research would therefore benefit from a longitudinal approach, investigating the interaction between proline and COMT on the change in negative symptoms assessed via the SANS or Positive and Negative Symptom Scale, in a large sample of both schizophrenia and bipolar disorder patients. The gene discussed is COMT; the disease is bipolar disorder.